Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PHM | SNX |
|---|---|---|
| Price | $115.55 | $273.97 |
| Change today | ▼ 0.44% | ▲ 6.67% |
| Market cap | $21.66B | $21.66B |
| Return, 3 months | -12.7% | +5.0% |
| Return, year to date | -0.8% | +83.7% |
| Return, 1 year | -13.3% | +68.4% |
| P/E (TTM) | 11.8 | 16.7 |
| P/B | 1.7 | 2.3 |
| P/E percentile vs own 5y | 92nd | 40th |
| Dividend yield | 0.87% | 0.69% |
| Revenue growth (YoY, latest qtr) | -9.6% | +37.7% |
| Net profit growth (YoY) | -22.4% | +83.5% |
| Gross margin | 25.2% | 6.9% |
| Operating margin | 15.6% | 2.7% |
| Net margin | 11.6% | 1.7% |
| Return on equity | 14.9% | 14.9% |
| Analyst target vs. price | +26.5% | +24.9% |
| Analyst buy share | 64% | 86% |
| RSI (14) | 39 | 46 |
| 30-day volatility | 28.0% | 45.8% |
| Max drawdown, 1 year | -22.6% | -18.8% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
